Genetic vaccination against leishmaniasis |
| |
Authors: | Damo Xu and F Y Liew |
| |
Institution: | Department of Immunology, University of Glasgow, Western Infirmary, Glasgow G11 6NT, UK. |
| |
Abstract: | The gene encoding for a major surface glycoprotein, gp63, of Leishmania major was cloned into the eukaryotic expression plasmid pCDNAI with CMV or RSV promoters. The highly susceptible Balb/c mice were injected intramuscularly with 100 μg/mouse of the purified plasmid. The plasmids were found to be stable in vivo for at least 40 days after injection and expressed significant levels of gp63, demonstrable by immunohistological staining with specific antibody. The immunized mice developed significant resistance against L. major infection compared to controls similarly immunized with the empty plasmid. Spleen cells from the immunized mice produced significant levels of IL-2 and IFN-γ but no detectable IL-4 when cultured with leishmanial antigens in vitro. |
| |
Keywords: | Leishmaniasis genetic vaccine surface glycoprotein gp63 |
本文献已被 ScienceDirect 等数据库收录! |
|